White label ELPA - ClinicalTrials.eu

Study of isatuximab, evorpacept and dexamethasone combination therapy for patients with relapsed or refractory multiple myeloma

Recruiting

1 1 1 1
Investigated diseases:
- Plasma cell myeloma refractory
Investigated drugs:
- Dexamethasone
- Isatuximab
Study of isatuximab, pomalidomide and dexamethasone combination for patients with relapsed or refractory multiple myeloma

Recruiting

1 1 1 1
Investigated diseases:
- Plasma cell myeloma refractory
Investigated drugs:
Study of isatuximab, belumosudil and dexamethasone combination treatment for patients with relapsed or refractory multiple myeloma

Recruiting

1 1 1 1
Investigated diseases:
- Plasma cell myeloma refractory
Investigated drugs:
Study on the Effects of Dexamethasone and Olanzapine in Patients Resuscitated from Out-of-Hospital Cardiac Arrest

Recruiting

3 1 1
Investigated diseases:
- Cardiac arrest
Investigated drugs:
Study on the Effect of Atorvastatin in Slowing Down Arrhythmogenic Cardiomyopathy Progression in Patients with the Condition

Recruiting

2 1 1
Investigated diseases:
- Arrhythmogenic right ventricular dysplasia
Investigated drugs:
- Atorvastatin
Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

Recruiting

2 1 1
Investigated diseases:
Investigated drugs:
- Ds-3939A
Study on Oxaliplatin with Drug Combination for Patients with Advanced Peritoneal Metastasis from Colorectal Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Colorectal cancer
Investigated drugs:
Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

Recruiting

4 1 1 1
Investigated diseases:
- Deafness neurosensory
Investigated drugs:
- Nitrous Oxide
- Oxygen
Evaluation of Contrast-Enhanced Spectral Mammography Using Iopromide in Women with Suspicious Breast Lesions to Improve Diagnostic Accuracy

Recruiting

2 1 1 1
Investigated drugs:
- Iopromide
Study of Personalized Peptide Vaccine with PERVI-FUS, PERVI-NEO, and 11902A for Children and Young Adults with Metastatic Fusion-Driven Sarcomas

Recruiting

2 1 1
Investigated diseases:
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies